Jain Garima, Kumar Chandan, Malhotra Ankit, Mallick Soumya Ranjan, Bakhshi Sameer, Chopra Anita
Laboratory Oncology Unit, Dr. B.R.A.I.R.C.H, All India Institute of Medical Sciences New Delhi, India.
Department of Pathology, All India Institute of Medical Sciences New Delhi, India.
Am J Blood Res. 2020 Oct 15;10(5):257-265. eCollection 2020.
Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive variant of peripheral T-cell lymphoma, occurring in elderly patients without any gender predisposition. It accounts for 1-2% of all non-Hodgkin lymphoma. Although characterized by some peculiar histological features, diagnosis of AITL can sometimes be challenging and a definite diagnosis requires a complete immunophenotypic and molecular workup. Peripheral Blood (PB) involvement in AITL has not been studied in detail and there is a paucity of published data about leukemic presentation of AITL. We present a case of a 38-year-old female diagnosed as AITL with PB involvement. Flow cytometric (FCM) examination of PB showed 40% abnormal lymphoid cells which were CD45+, CD4+, CD2+, cCD3+, CD5+, CD10+, CD16+ and TCRγδ restricted. PB involvement by AITL appears to be more common and under-reported. Nevertheless, detection of these tumoral T lymphocytes needs to be assessed in large case studies for assessing the true incidence of PB involvement. FCM analysis is an effective and reliable approach in the identification of leukemic phase of AITL and can lead to timely and effective intervention.
血管免疫母细胞性T细胞淋巴瘤(AITL)是外周T细胞淋巴瘤的一种侵袭性亚型,好发于老年患者,无明显性别倾向。它占所有非霍奇金淋巴瘤的1%-2%。尽管AITL具有一些独特的组织学特征,但有时诊断具有挑战性,明确诊断需要完整的免疫表型和分子检查。AITL外周血(PB)受累情况尚未得到详细研究,关于AITL白血病表现的已发表数据也很少。我们报告一例38岁女性被诊断为AITL伴PB受累的病例。PB的流式细胞术(FCM)检查显示40%的异常淋巴细胞,这些细胞CD45+、CD4+、CD2+、胞质CD3+、CD5+、CD10+、CD16+且TCRγδ受限。AITL的PB受累似乎更为常见但报道不足。然而,需要通过大型病例研究评估这些肿瘤性T淋巴细胞的检测情况,以评估PB受累的真实发生率。FCM分析是识别AITL白血病期的有效且可靠的方法,可实现及时有效的干预。